Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy
The systemic inflammatory syndrome called "cytokine storm" has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of cytokine and chemokine levels in the blood of 21 SARS-CoV-2 positive patients throughout the phases of the pandemic has been studied to...
Saved in:
| Published in | BMC immunology Vol. 25; no. 1; pp. 49 - 9 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
26.07.2024
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2172 1471-2172 |
| DOI | 10.1186/s12865-024-00641-z |
Cover
Loading…
| Abstract | The systemic inflammatory syndrome called "cytokine storm" has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of cytokine and chemokine levels in the blood of 21 SARS-CoV-2 positive patients throughout the phases of the pandemic has been studied to understand immune response dysregulation and identify potential disease biomarkers for new treatments. The present work reports the cytokine and chemokine levels in sera from a small cohort of individuals primarily infected with SARS-CoV-2 during the first wave of the COVID-19 pandemic in Milan (Italy).
Among the 27 cytokines and chemokines investigated, a significant higher expression of Interleukin-9 (IL-9), IP-10 (CXCL10), MCP-1 (CCL2) and RANTES (CCL-5) in infected patients compared to uninfected subjects was observed. When the change in cytokine/chemokine levels was monitored over time, from the hospitalization day to discharge, only IL-6 and IP-10 showed a significant decrease. Consistent with these findings, a significant negative correlation was observed between IP-10 and anti-Spike IgG antibodies in infected individuals. In contrast, IL-17 was positively correlated with the production of IgG against SARS-CoV-2.
The cytokine storm and the modulation of cytokine levels by SARS-CoV-2 infection are hallmarks of COVID-19. The current global immunity profile largely stems from widespread vaccination campaigns and previous infection exposures. Consequently, the immunological features and dynamic cytokine profiles of non-vaccinated and primarily-infected subjects reported here provide novel insights into the inflammatory immune landscape in the context of SARS-CoV-2 infection, and offer valuable knowledge for addressing future viral infections and the development of novel treatments. |
|---|---|
| AbstractList | The systemic inflammatory syndrome called "cytokine storm" has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of cytokine and chemokine levels in the blood of 21 SARS-CoV-2 positive patients throughout the phases of the pandemic has been studied to understand immune response dysregulation and identify potential disease biomarkers for new treatments. The present work reports the cytokine and chemokine levels in sera from a small cohort of individuals primarily infected with SARS-CoV-2 during the first wave of the COVID-19 pandemic in Milan (Italy). Among the 27 cytokines and chemokines investigated, a significant higher expression of Interleukin-9 (IL-9), IP-10 (CXCL10), MCP-1 (CCL2) and RANTES (CCL-5) in infected patients compared to uninfected subjects was observed. When the change in cytokine/chemokine levels was monitored over time, from the hospitalization day to discharge, only IL-6 and IP-10 showed a significant decrease. Consistent with these findings, a significant negative correlation was observed between IP-10 and anti-Spike IgG antibodies in infected individuals. In contrast, IL-17 was positively correlated with the production of IgG against SARS-CoV-2. The cytokine storm and the modulation of cytokine levels by SARS-CoV-2 infection are hallmarks of COVID-19. The current global immunity profile largely stems from widespread vaccination campaigns and previous infection exposures. Consequently, the immunological features and dynamic cytokine profiles of non-vaccinated and primarily-infected subjects reported here provide novel insights into the inflammatory immune landscape in the context of SARS-CoV-2 infection, and offer valuable knowledge for addressing future viral infections and the development of novel treatments. Abstract Background The systemic inflammatory syndrome called “cytokine storm” has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of cytokine and chemokine levels in the blood of 21 SARS-CoV-2 positive patients throughout the phases of the pandemic has been studied to understand immune response dysregulation and identify potential disease biomarkers for new treatments. The present work reports the cytokine and chemokine levels in sera from a small cohort of individuals primarily infected with SARS-CoV-2 during the first wave of the COVID-19 pandemic in Milan (Italy). Results Among the 27 cytokines and chemokines investigated, a significant higher expression of Interleukin-9 (IL-9), IP-10 (CXCL10), MCP-1 (CCL2) and RANTES (CCL-5) in infected patients compared to uninfected subjects was observed. When the change in cytokine/chemokine levels was monitored over time, from the hospitalization day to discharge, only IL-6 and IP-10 showed a significant decrease. Consistent with these findings, a significant negative correlation was observed between IP-10 and anti-Spike IgG antibodies in infected individuals. In contrast, IL-17 was positively correlated with the production of IgG against SARS-CoV-2. Conclusions The cytokine storm and the modulation of cytokine levels by SARS-CoV-2 infection are hallmarks of COVID-19. The current global immunity profile largely stems from widespread vaccination campaigns and previous infection exposures. Consequently, the immunological features and dynamic cytokine profiles of non-vaccinated and primarily-infected subjects reported here provide novel insights into the inflammatory immune landscape in the context of SARS-CoV-2 infection, and offer valuable knowledge for addressing future viral infections and the development of novel treatments. BackgroundThe systemic inflammatory syndrome called “cytokine storm” has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of cytokine and chemokine levels in the blood of 21 SARS-CoV-2 positive patients throughout the phases of the pandemic has been studied to understand immune response dysregulation and identify potential disease biomarkers for new treatments. The present work reports the cytokine and chemokine levels in sera from a small cohort of individuals primarily infected with SARS-CoV-2 during the first wave of the COVID-19 pandemic in Milan (Italy).ResultsAmong the 27 cytokines and chemokines investigated, a significant higher expression of Interleukin-9 (IL-9), IP-10 (CXCL10), MCP-1 (CCL2) and RANTES (CCL-5) in infected patients compared to uninfected subjects was observed. When the change in cytokine/chemokine levels was monitored over time, from the hospitalization day to discharge, only IL-6 and IP-10 showed a significant decrease. Consistent with these findings, a significant negative correlation was observed between IP-10 and anti-Spike IgG antibodies in infected individuals. In contrast, IL-17 was positively correlated with the production of IgG against SARS-CoV-2.ConclusionsThe cytokine storm and the modulation of cytokine levels by SARS-CoV-2 infection are hallmarks of COVID-19. The current global immunity profile largely stems from widespread vaccination campaigns and previous infection exposures. Consequently, the immunological features and dynamic cytokine profiles of non-vaccinated and primarily-infected subjects reported here provide novel insights into the inflammatory immune landscape in the context of SARS-CoV-2 infection, and offer valuable knowledge for addressing future viral infections and the development of novel treatments. The systemic inflammatory syndrome called "cytokine storm" has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of cytokine and chemokine levels in the blood of 21 SARS-CoV-2 positive patients throughout the phases of the pandemic has been studied to understand immune response dysregulation and identify potential disease biomarkers for new treatments. The present work reports the cytokine and chemokine levels in sera from a small cohort of individuals primarily infected with SARS-CoV-2 during the first wave of the COVID-19 pandemic in Milan (Italy). Among the 27 cytokines and chemokines investigated, a significant higher expression of Interleukin-9 (IL-9), IP-10 (CXCL10), MCP-1 (CCL2) and RANTES (CCL-5) in infected patients compared to uninfected subjects was observed. When the change in cytokine/chemokine levels was monitored over time, from the hospitalization day to discharge, only IL-6 and IP-10 showed a significant decrease. Consistent with these findings, a significant negative correlation was observed between IP-10 and anti-Spike IgG antibodies in infected individuals. In contrast, IL-17 was positively correlated with the production of IgG against SARS-CoV-2. The cytokine storm and the modulation of cytokine levels by SARS-CoV-2 infection are hallmarks of COVID-19. The current global immunity profile largely stems from widespread vaccination campaigns and previous infection exposures. Consequently, the immunological features and dynamic cytokine profiles of non-vaccinated and primarily-infected subjects reported here provide novel insights into the inflammatory immune landscape in the context of SARS-CoV-2 infection, and offer valuable knowledge for addressing future viral infections and the development of novel treatments. Background The systemic inflammatory syndrome called "cytokine storm" has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of cytokine and chemokine levels in the blood of 21 SARS-CoV-2 positive patients throughout the phases of the pandemic has been studied to understand immune response dysregulation and identify potential disease biomarkers for new treatments. The present work reports the cytokine and chemokine levels in sera from a small cohort of individuals primarily infected with SARS-CoV-2 during the first wave of the COVID-19 pandemic in Milan (Italy). Results Among the 27 cytokines and chemokines investigated, a significant higher expression of Interleukin-9 (IL-9), IP-10 (CXCL10), MCP-1 (CCL2) and RANTES (CCL-5) in infected patients compared to uninfected subjects was observed. When the change in cytokine/chemokine levels was monitored over time, from the hospitalization day to discharge, only IL-6 and IP-10 showed a significant decrease. Consistent with these findings, a significant negative correlation was observed between IP-10 and anti-Spike IgG antibodies in infected individuals. In contrast, IL-17 was positively correlated with the production of IgG against SARS-CoV-2. Conclusions The cytokine storm and the modulation of cytokine levels by SARS-CoV-2 infection are hallmarks of COVID-19. The current global immunity profile largely stems from widespread vaccination campaigns and previous infection exposures. Consequently, the immunological features and dynamic cytokine profiles of non-vaccinated and primarily-infected subjects reported here provide novel insights into the inflammatory immune landscape in the context of SARS-CoV-2 infection, and offer valuable knowledge for addressing future viral infections and the development of novel treatments. Keywords: COVID-19, SARS-CoV-2, Primarily-infected subjects, Serum cytokine/chemokines levels, Anti-SARS-CoV-2 IgG The systemic inflammatory syndrome called "cytokine storm" has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of cytokine and chemokine levels in the blood of 21 SARS-CoV-2 positive patients throughout the phases of the pandemic has been studied to understand immune response dysregulation and identify potential disease biomarkers for new treatments. The present work reports the cytokine and chemokine levels in sera from a small cohort of individuals primarily infected with SARS-CoV-2 during the first wave of the COVID-19 pandemic in Milan (Italy).BACKGROUNDThe systemic inflammatory syndrome called "cytokine storm" has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of cytokine and chemokine levels in the blood of 21 SARS-CoV-2 positive patients throughout the phases of the pandemic has been studied to understand immune response dysregulation and identify potential disease biomarkers for new treatments. The present work reports the cytokine and chemokine levels in sera from a small cohort of individuals primarily infected with SARS-CoV-2 during the first wave of the COVID-19 pandemic in Milan (Italy).Among the 27 cytokines and chemokines investigated, a significant higher expression of Interleukin-9 (IL-9), IP-10 (CXCL10), MCP-1 (CCL2) and RANTES (CCL-5) in infected patients compared to uninfected subjects was observed. When the change in cytokine/chemokine levels was monitored over time, from the hospitalization day to discharge, only IL-6 and IP-10 showed a significant decrease. Consistent with these findings, a significant negative correlation was observed between IP-10 and anti-Spike IgG antibodies in infected individuals. In contrast, IL-17 was positively correlated with the production of IgG against SARS-CoV-2.RESULTSAmong the 27 cytokines and chemokines investigated, a significant higher expression of Interleukin-9 (IL-9), IP-10 (CXCL10), MCP-1 (CCL2) and RANTES (CCL-5) in infected patients compared to uninfected subjects was observed. When the change in cytokine/chemokine levels was monitored over time, from the hospitalization day to discharge, only IL-6 and IP-10 showed a significant decrease. Consistent with these findings, a significant negative correlation was observed between IP-10 and anti-Spike IgG antibodies in infected individuals. In contrast, IL-17 was positively correlated with the production of IgG against SARS-CoV-2.The cytokine storm and the modulation of cytokine levels by SARS-CoV-2 infection are hallmarks of COVID-19. The current global immunity profile largely stems from widespread vaccination campaigns and previous infection exposures. Consequently, the immunological features and dynamic cytokine profiles of non-vaccinated and primarily-infected subjects reported here provide novel insights into the inflammatory immune landscape in the context of SARS-CoV-2 infection, and offer valuable knowledge for addressing future viral infections and the development of novel treatments.CONCLUSIONSThe cytokine storm and the modulation of cytokine levels by SARS-CoV-2 infection are hallmarks of COVID-19. The current global immunity profile largely stems from widespread vaccination campaigns and previous infection exposures. Consequently, the immunological features and dynamic cytokine profiles of non-vaccinated and primarily-infected subjects reported here provide novel insights into the inflammatory immune landscape in the context of SARS-CoV-2 infection, and offer valuable knowledge for addressing future viral infections and the development of novel treatments. |
| ArticleNumber | 49 |
| Audience | Academic |
| Author | D’Alessandro, Sarah Maina, Kevin Kamau Perego, Federica Zanotta, Nunzia Pizzocri, Pierluigi Ferrante, Pasquale Calvo-Alvarez, Estefanía Modenese, Annalisa Basilico, Nicoletta Ronsivalle, Andrea Delbue, Serena Comar, Manola Signorini, Lucia Parapini, Silvia |
| Author_xml | – sequence: 1 givenname: Estefanía surname: Calvo-Alvarez fullname: Calvo-Alvarez, Estefanía – sequence: 2 givenname: Sarah surname: D’Alessandro fullname: D’Alessandro, Sarah – sequence: 3 givenname: Nunzia surname: Zanotta fullname: Zanotta, Nunzia – sequence: 4 givenname: Nicoletta surname: Basilico fullname: Basilico, Nicoletta – sequence: 5 givenname: Silvia surname: Parapini fullname: Parapini, Silvia – sequence: 6 givenname: Lucia surname: Signorini fullname: Signorini, Lucia – sequence: 7 givenname: Federica surname: Perego fullname: Perego, Federica – sequence: 8 givenname: Kevin Kamau surname: Maina fullname: Maina, Kevin Kamau – sequence: 9 givenname: Pasquale surname: Ferrante fullname: Ferrante, Pasquale – sequence: 10 givenname: Annalisa surname: Modenese fullname: Modenese, Annalisa – sequence: 11 givenname: Pierluigi surname: Pizzocri fullname: Pizzocri, Pierluigi – sequence: 12 givenname: Andrea surname: Ronsivalle fullname: Ronsivalle, Andrea – sequence: 13 givenname: Serena surname: Delbue fullname: Delbue, Serena – sequence: 14 givenname: Manola surname: Comar fullname: Comar, Manola |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39061002$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kttu1DAQhiNURA_wAlwgS9yARIoPsZNcrpbTSq0qdaG31qwz2bpk48V2oNsH4XlxukuhFUK5cDz6_t_j8X-Y7fWuxyx7zugxY5V6GxivlMwpL3JKVcHym0fZAStKlnNW8r2__vezwxCuKGVlxasn2b6oqWKU8oPs5-nQRbvu8JqA97Ah0EO3CTYQ1xJjvRk6iLZfErOJ7qvtMSSiIeYSV7ut7cn07GL2Lmc1WScW-xhIM_hRFC-RtNaHSH7Adxwtx8p8cj7Pp-4i50nQN7iyZnQ5tR30b8gspgaeZo9b6AI-261H2ZcP7z9PP-UnZx9n08lJbmTBY45CojFCghFCtQUKYVhZV1KKuqBMlU2tuKkrlLyFYtHIVmKjKAW1qLnhUoijbLb1bRxc6bW3K_Ab7cDq24LzSw0-WtOhVrhgC6EEgikKaJIrhcYg5bIRom0heb3aeq29-zZgiHplg8Eu3QrdELSglWRMVqpM6MsH6JUbfJr8SNWM17Quqj_UEtL5tm9d9GBGUz2pKC_Tk5cqUcf_oNJ3O9iUmNam-j3B63uCxES8jksYQtCz-fl99sWu0WGxwuZuQr8DlAC-BYx3IXhs7xBG9ZhSvU2pTinVtynVN0lUPRAZG1N0UiMebPc_6S8VCOjX |
| CitedBy_id | crossref_primary_10_1161_CIRCRESAHA_124_325023 crossref_primary_10_22265_acnef_12_1_846 crossref_primary_10_3390_ijms252111411 |
| Cites_doi | 10.1038/s41590-021-01122-w 10.1146/annurev.iy.07.040189.001045 10.1038/s41586-020-2456-9 10.1016/j.jaccas.2020.03.012 10.1016/j.jaci.2020.04.027 10.1056/NEJMoa2023184 10.1002/jmv.25900 10.3899/jrheum.200726 10.1016/j.ijid.2022.05.051 10.1186/s10020-020-00230-x 10.3389/fimmu.2021.613422 10.1038/s41591-020-1051-9 10.1177/0961203312437270 10.1016/j.cyto.2020.155389 10.1016/j.cyto.2020.155323 10.6061/clinics/2013(06)07 10.1016/s0161-5890(02)00210-9 10.1111/bcp.14437 10.3389/fimmu.2021.700921 10.1111/sji.12989 10.1111/j.1440-1843.2010.01897.x 10.3389/fimmu.2020.00827 10.1186/s13578-020-00519-8 10.1093/infdis/jiaa753 10.1136/thx.2009.132480 10.3389/fcimb.2022.835750 10.1016/j.mehy.2020.109749 10.1016/j.jcv.2017.03.003 10.26402/jpp.2021.4.01 10.1038/s41598-022-14571-6 10.1126/sciimmunol.abe0240 10.1016/j.jneuroim.2017.06.012 10.1002/jmv.27287 10.1189/jlb.1102577 10.3390/ijms23074063 10.1038/s41392-021-00679-0 10.1016/S0140-6736(20)30628-0 10.1097/01.ccm.0000149854.61192.dc 10.3390/ijms232214146 10.3389/fimmu.2022.946730 10.3389/fgene.2021.706902 10.1038/s41598-020-78710-7 10.4049/jimmunol.0900085 |
| ContentType | Journal Article |
| Copyright | 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7T5 7X7 7XB 88E 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 DOA |
| DOI | 10.1186/s12865-024-00641-z |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1471-2172 |
| EndPage | 9 |
| ExternalDocumentID | oai_doaj_org_article_6eb1b363eac44ad98e0adce025d33ffa A802764176 39061002 10_1186_s12865_024_00641_z |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Italy Milan Italy |
| GeographicLocations_xml | – name: Italy – name: Milan Italy |
| GrantInformation_xml | – fundername: Università degli Studi di Milano grantid: GSA-IDEA project – fundername: Ministero dell'Università e della Ricerca grantid: 2022Y8FZCP – fundername: the NextGeneration EU-MUR PNRR Extended Partnership initiative grantid: PE00000007, INF-ACT |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR ISR ITC KQ8 LGEZI LOTEE M1P M48 M7P M~E NADUK NXXTH O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB PMFND 3V. 7T5 7XB 8FE 8FH 8FK AZQEC COVID DWQXO GNUQQ H94 K9. LK8 PKEHL PQEST PQQKQ PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c542t-e35ecc35ac336f4e33c1798553940167d962c98e52fa4bd5f5ed600a6b92c2533 |
| IEDL.DBID | 7X7 |
| ISSN | 1471-2172 |
| IngestDate | Wed Aug 27 01:31:38 EDT 2025 Thu Jul 10 23:57:00 EDT 2025 Fri Jul 25 19:20:40 EDT 2025 Tue Jun 17 22:07:45 EDT 2025 Tue Jun 10 21:05:35 EDT 2025 Fri Jun 27 05:53:34 EDT 2025 Tue Aug 19 01:31:02 EDT 2025 Tue Jul 01 03:29:41 EDT 2025 Thu Apr 24 22:54:07 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | COVID-19 Primarily-infected subjects SARS-CoV-2 Anti-SARS-CoV-2 IgG Serum cytokine/chemokines levels |
| Language | English |
| License | 2024. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c542t-e35ecc35ac336f4e33c1798553940167d962c98e52fa4bd5f5ed600a6b92c2533 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/3091290948?pq-origsite=%requestingapplication% |
| PMID | 39061002 |
| PQID | 3091290948 |
| PQPubID | 44823 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6eb1b363eac44ad98e0adce025d33ffa proquest_miscellaneous_3085115867 proquest_journals_3091290948 gale_infotracmisc_A802764176 gale_infotracacademiconefile_A802764176 gale_incontextgauss_ISR_A802764176 pubmed_primary_39061002 crossref_primary_10_1186_s12865_024_00641_z crossref_citationtrail_10_1186_s12865_024_00641_z |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-07-26 |
| PublicationDateYYYYMMDD | 2024-07-26 |
| PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-26 day: 26 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC immunology |
| PublicationTitleAlternate | BMC Immunol |
| PublicationYear | 2024 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | P Moss (641_CR40) 2022; 23 TR Mosmann (641_CR41) 1989; 7 C Indolfi (641_CR2) 2020; 2 XH Luo (641_CR45) 2021; 93 641_CR24 S Diehl (641_CR42) 2002; 39 L Yang (641_CR6) 2021; 6 MM Medina-Enríquez (641_CR4) 2020; 10 Y Chen (641_CR17) 2020; 26 J Zheng (641_CR8) 2021; 223 SA Tegethoff (641_CR23) 2022; 122 P Kidd (641_CR43) 2003; 8 MS Hayney (641_CR21) 2017; 90 641_CR16 A Ghazavi (641_CR25) 2021; 137 MJ Pons (641_CR30) 2021; 12 641_CR10 P Mehta (641_CR7) 2020; 395 S Bülow Anderberg (641_CR14) 2020; 138 KC Sumino (641_CR22) 2010; 65 JC Silva (641_CR36) 2013; 68 C Song (641_CR1) 2022; 12 J Melchjorsen (641_CR18) 2003; 74 L Sánchez-de Prada (641_CR9) 2022; 13 V Bulat (641_CR32) 2021; 87 R Dolscheid-Pommerich (641_CR34) 2022; 94 JS Dodd (641_CR26) 2009; 183 B Diao (641_CR13) 2020; 11 DM Del Valle (641_CR15) 2020; 26 LG Wood (641_CR20) 2011; 16 M Megna (641_CR31) 2020; 140 Y Yang (641_CR19) 2020; 146 WM Lambers (641_CR37) 2021; 48 R Willis (641_CR39) 2012; 21 641_CR5 DF Robbiani (641_CR33) 2020; 584 641_CR3 AB Pavel (641_CR12) 2021; 12 H Pan (641_CR38) 2021; 384 S Villani (641_CR11) 2017; 310 R Wakiya (641_CR35) 2022; 12 641_CR29 641_CR28 A Santa Cruz (641_CR27) 2021; 12 FA Lagunas-Rangel (641_CR44) 2020; 92 |
| References_xml | – ident: 641_CR10 – volume: 23 start-page: 186 year: 2022 ident: 641_CR40 publication-title: Nat Immunol doi: 10.1038/s41590-021-01122-w – volume: 7 start-page: 145 year: 1989 ident: 641_CR41 publication-title: Annu Rev Immunol doi: 10.1146/annurev.iy.07.040189.001045 – volume: 584 start-page: 437 year: 2020 ident: 641_CR33 publication-title: Nature doi: 10.1038/s41586-020-2456-9 – volume: 2 start-page: 1414 year: 2020 ident: 641_CR2 publication-title: JACC Case Rep doi: 10.1016/j.jaccas.2020.03.012 – volume: 146 start-page: 119 year: 2020 ident: 641_CR19 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2020.04.027 – volume: 384 start-page: 497 year: 2021 ident: 641_CR38 publication-title: N Engl J Med doi: 10.1056/NEJMoa2023184 – volume: 92 start-page: 1789 year: 2020 ident: 641_CR44 publication-title: J Med Virol doi: 10.1002/jmv.25900 – volume: 48 start-page: 847 year: 2021 ident: 641_CR37 publication-title: J Rheumatol doi: 10.3899/jrheum.200726 – volume: 122 start-page: 178 year: 2022 ident: 641_CR23 publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2022.05.051 – volume: 26 start-page: 97 year: 2020 ident: 641_CR17 publication-title: Mol Med doi: 10.1186/s10020-020-00230-x – volume: 12 start-page: 613422 year: 2021 ident: 641_CR27 publication-title: Front Immunol doi: 10.3389/fimmu.2021.613422 – volume: 26 start-page: 1636 year: 2020 ident: 641_CR15 publication-title: Nat Med doi: 10.1038/s41591-020-1051-9 – volume: 21 start-page: 830 year: 2012 ident: 641_CR39 publication-title: Lupus doi: 10.1177/0961203312437270 – volume: 138 start-page: 155389 year: 2020 ident: 641_CR14 publication-title: Cytokine doi: 10.1016/j.cyto.2020.155389 – volume: 137 start-page: 155323 year: 2021 ident: 641_CR25 publication-title: Cytokine doi: 10.1016/j.cyto.2020.155323 – volume: 68 start-page: 766 year: 2013 ident: 641_CR36 publication-title: Clin (Sao Paulo) doi: 10.6061/clinics/2013(06)07 – volume: 39 start-page: 531 year: 2002 ident: 641_CR42 publication-title: Mol Immunol doi: 10.1016/s0161-5890(02)00210-9 – volume: 87 start-page: 1578 year: 2021 ident: 641_CR32 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.14437 – volume: 12 start-page: 700921 year: 2021 ident: 641_CR30 publication-title: Front Immunol doi: 10.3389/fimmu.2021.700921 – volume: 93 start-page: e12989 year: 2021 ident: 641_CR45 publication-title: Scand J Immunol doi: 10.1111/sji.12989 – volume: 16 start-page: 291 year: 2011 ident: 641_CR20 publication-title: Respirology doi: 10.1111/j.1440-1843.2010.01897.x – volume: 11 start-page: 827 year: 2020 ident: 641_CR13 publication-title: Front Immunol doi: 10.3389/fimmu.2020.00827 – volume: 10 start-page: 148 year: 2020 ident: 641_CR4 publication-title: Cell Biosci doi: 10.1186/s13578-020-00519-8 – volume: 223 start-page: 785 year: 2021 ident: 641_CR8 publication-title: J Infect Dis doi: 10.1093/infdis/jiaa753 – volume: 65 start-page: 639 year: 2010 ident: 641_CR22 publication-title: Thorax doi: 10.1136/thx.2009.132480 – volume: 12 start-page: 835750 year: 2022 ident: 641_CR1 publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2022.835750 – volume: 140 start-page: 109749 year: 2020 ident: 641_CR31 publication-title: Med Hypotheses doi: 10.1016/j.mehy.2020.109749 – volume: 90 start-page: 32 year: 2017 ident: 641_CR21 publication-title: J Clin Virol doi: 10.1016/j.jcv.2017.03.003 – ident: 641_CR3 doi: 10.26402/jpp.2021.4.01 – volume: 12 start-page: 10175 year: 2022 ident: 641_CR35 publication-title: Sci Rep doi: 10.1038/s41598-022-14571-6 – ident: 641_CR29 doi: 10.1126/sciimmunol.abe0240 – volume: 8 start-page: 223 year: 2003 ident: 641_CR43 publication-title: Altern Med Rev – volume: 310 start-page: 91 year: 2017 ident: 641_CR11 publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2017.06.012 – volume: 94 start-page: 388 year: 2022 ident: 641_CR34 publication-title: J Med Virol doi: 10.1002/jmv.27287 – volume: 74 start-page: 331 year: 2003 ident: 641_CR18 publication-title: J Leukoc Biol doi: 10.1189/jlb.1102577 – ident: 641_CR5 doi: 10.3390/ijms23074063 – volume: 6 start-page: 255 year: 2021 ident: 641_CR6 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-021-00679-0 – volume: 395 start-page: 1033 year: 2020 ident: 641_CR7 publication-title: Lancet doi: 10.1016/S0140-6736(20)30628-0 – ident: 641_CR28 doi: 10.1097/01.ccm.0000149854.61192.dc – ident: 641_CR24 doi: 10.3390/ijms232214146 – volume: 13 start-page: 946730 year: 2022 ident: 641_CR9 publication-title: Front Immunol doi: 10.3389/fimmu.2022.946730 – volume: 12 start-page: 706902 year: 2021 ident: 641_CR12 publication-title: Front Genet doi: 10.3389/fgene.2021.706902 – ident: 641_CR16 doi: 10.1038/s41598-020-78710-7 – volume: 183 start-page: 7006 year: 2009 ident: 641_CR26 publication-title: J Immunol doi: 10.4049/jimmunol.0900085 |
| SSID | ssj0017828 |
| Score | 2.3666368 |
| Snippet | The systemic inflammatory syndrome called "cytokine storm" has been described in COVID-19 pathogenesis, contributing to disease severity. The analysis of... Background The systemic inflammatory syndrome called "cytokine storm" has been described in COVID-19 pathogenesis, contributing to disease severity. The... BackgroundThe systemic inflammatory syndrome called “cytokine storm” has been described in COVID-19 pathogenesis, contributing to disease severity. The... Abstract Background The systemic inflammatory syndrome called “cytokine storm” has been described in COVID-19 pathogenesis, contributing to disease severity.... |
| SourceID | doaj proquest gale pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source |
| StartPage | 49 |
| SubjectTerms | Aged Aged, 80 and over Analysis Anti-SARS-CoV-2 IgG Antibodies, Viral - blood Antibodies, Viral - immunology Blood levels Chemokines Chemokines - blood Chemokines - immunology COVID-19 COVID-19 - diagnosis COVID-19 - epidemiology COVID-19 - immunology COVID-19 Drug Treatment CXCL10 protein Cytokine storm Cytokines Cytokines - blood Cytokines - immunology Hospitalization Humans Immune response Immunoglobulin G Immunoglobulin G - blood Immunoglobulin G - immunology Infections Inflammation Interleukin 9 Interleukins IP-10 protein Italy - epidemiology Male Microarray Analysis - methods Middle Aged Monocyte chemoattractant protein 1 Pandemics Pneumonia Primarily-infected subjects RANTES Receptors, Cytokine - blood Receptors, Cytokine - immunology SARS-CoV-2 Serum cytokine/chemokines levels Severe acute respiratory syndrome coronavirus 2 Th1 Cells - immunology Th2 Cells - immunology Vaccination |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQJBAvCMZXYCCDkHgAa4sdu_FjKUwrUkFa2bQ3y_HHVG0kqGmB7g_h7-UucSsKErzw2OTsJr7z3c_K3e8IeSGs8rqwiomoPCsgRDNdhIohMUjhpYzeY-3w5IM6Oinen8mzX1p9YU5YTw_cL9y-AmdSCSXAQRSF9boMB9a7AKHaCxFjB40g5q0PU-n7AcS9cl0iU6r9NscCTAbxiGEMztnVVhjq2Pr_9Mm_Ic0u4hzeJrcSVKTD_hHvkGuh3iXX--aRq11yY5I-i98lPyYpLfA7tfO5XVGbqEZoE6mbzV3Xo6s-p261aC4w0R0kPAV9fU4_ZzUdfTwdv2W5polqtaV9CSMFiEjjDFAi_Wa_BpwSr0yHx1M2ak4ZhwF1l2OPs0xml7Z-TceA6Vf3yMnhu0-jI5YaLjAnC75gQUjQqJDWCaFiEYRwyGcmJbZPz9XAa8UdaEDyaIvKyyiDB8BkVaW54wAc75OduqnDQ0Jl1CKANwgO4p-OHHwquAuYL48H3iubkXy9_sYlNnJsinFpulNJqUyvMwM6M53OzFVGXm3GfOm5OP4q_QbVupFEHu3uAliXSdZl_mVdGXmORmGQKaPGVJxzu2xbM54em2EJJ3r4p4HKyMskFBt4B2dTZQOsBJJrbUnubUnCVnbbt9e2Z5IraY0A6-YaTuFlRp5tbuNITI-rQ7NEGQTOslSDjDzobXbz3kIDZIO49-h_rMdjcpN3u2jAuNojO4v5MjwBVLaonnYb8Cc61zJn priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLbGEIgXBONWGMggJB7AY4kvTR4QKoVpRSpIK532Zrm-VNW6BNIW1v0Qfi_nJG5RYdpjkmMn9vHx91k5F0JecqNcLoxiPCjHBEA0y4UfMUwMIpyUwTmMHe5_UYdD8flEnmyRVbmjOIGzS492WE9qWE33zn8s34PBv6sNPlNvZwmGVzJAG4YIm7CLa-Q6IFMbDbUv_v5VADTMVoEzl7bbAKc6h___O_U__LPGoYM75HYkkLTTaPwu2fLFDrnRlJRc7pCb_fiz_B753Y_OgufUVJVZUhMTkNAyUDupbF25qxhTu5yXp-j-DhKOghbP4uWkoN2vx72PLMlpTMA6o01gIwXiSMMEuCP9ZX567BLvDDpHA9Ytj1kKDYra8x576U-mpnhDezDJy_tkePDpW_eQxTIMzEqRzpnnEvTMpbGcqyA85xaznEmJRdUT1Xa5Sm2eeZkGI0ZOBukd0CijRnlqU6CTD8h2URb-EaEy5NzDHuEtoGIeUthpYROB_pKw75wyLZKs5l_bmKMcS2VMdX1WyZRudKZBZ7rWmb5okdfrNt-bDB1XSn9Ata4lMbt2faOsxjoaq1YAYCOuOICSEMbB2PaNsx7ooeM8BPjMF7goNObPKNBBZ2wWs5nuDY50J4NzPryprVrkVRQKJYzBmhjvADOBKbc2JHc3JMHA7ebj1drTK_vQHHhemsPZPGuR5-vH2BKd5gpfLlAG6bTMVLtFHjZrdj1ungORAzR8fHXnT8ittLaPNkvVLtmeVwv_FFjYfPSsNq0_bHArfg priority: 102 providerName: Scholars Portal |
| Title | Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39061002 https://www.proquest.com/docview/3091290948 https://www.proquest.com/docview/3085115867 https://doaj.org/article/6eb1b363eac44ad98e0adce025d33ffa |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgE4gXBANGYVQGIfEA1pY4dpMn1JVNK1IHatm0N8v1j6piJKNpge4P4e_lznGLCtJeIiU5O3HOvu-zc74j5DXX0haZlox7aVkGEM2KzI0ZBgbJrBDeWtw7PDiVJ2fZxwtxERfc6uhWubKJwVDbyuAa-T4HYEsLmIzk76--M8wahX9XYwqN22QbQ5ehS1fnYj3hSgD98tVGmVzu1wluw2SASgyROGHXG2AUYvb_b5n_4ZsBd44fkPuRMNJuo-GH5JYrd8idJoXkcofcHcSf44_I70F0DvxF9Wyml1THgCO08tRMZyZk6ion1Czn1Vd0dwcJS0Fr3-LptKS9T-f9DywpaAy4WtNmIyMFokj9FLgi_al_OKwSr4y6wxHrVecshQJl8LTHWgbTS12-o31g9svH5Oz46EvvhMW0C8yILJ0zxwXolQttOJc-c5wbjGomBCZRT2THFjI1Re5E6nU2tsILZ4E2aTkuUpMCfXxCtsqqdE8JFb7gDmyCM4CChU_BsoLRgPoSf2Ct1C2SrL6_MjEmOabGuFRhbpJL1ehMgc5U0Jm6bpG36zJXTUSOG6UPUa1rSYymHS5Us4mKg1NJAKwxlxxAKMu0hbYdaGsc0EHLuffwmq-wUyiMl1GiQ85EL-pa9UdD1c1hXg9P6sgWeROFfAVtMDrub4AvgSG2NiT3NiRhQJvN26u-p6JBqdXf7t8iL9e3sSQ6yZWuWqAM0meRy06L7DZ9dt1uXgBxA_R7dnPlz8m9NIyPDkvlHtmazxbuBbCu-bgdhhYc817SJtuHR6efh-2wggHHQZb_AWzHLEw |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRTwuCMorUGBBIA501XjXu7EPCIWUKqFNkZq2ym3Z7COKKHbJg5L-EH4Gv5EZ2wkKSL31aHt27fXMzjdjz4OQV8Iol8ZGMRGUYzFANEtjP2BYGCR2UgbnMHe4e6Dax_Gnvuyvkd-LXBgMq1zoxEJRu9ziN_JtAcDGU3BGkvdn3xl2jcK_q4sWGqVY7Pn5Obhsk3edHeDva853Px612qzqKsCsjPmUeSHhsYU0VggVYi-ExaJdUmKP8Eg1XKq4TRMveTDxwMkgvQOrwKhByi2X-AEUVP41AN467qhGf-ngRYC2ySIxJ1HbkwjTPhmgIEPkj9jFCvgVPQL-R4J_7NsC53bvkNuVgUqbpUTdJWs-2yDXy5aV8w1yo1v9jL9HfnWrYMSf1IzHZk5NVeCE5oHa0dgWncGyIbXzaf4Vw-uBwlGQkm_V4Sijrc8nnR0WpbQq8DqhZeIkBcOUhhHYpvTc_PA4JZ7pNQ97rJWfMA4DsiKyH2fpjk5NtkU74EnM75PjK2HIA7Ke5Zl_RKgMqfCgg7wF1E0DB00OSgrmi0LdOWVqJFq8f22rGujYiuNUF75QonTJMw080wXP9EWNvF2OOSsrgFxK_QHZuqTE6t3FiXw81JUy0AoAciCUANCLY-NgbXXjrAfz0wkRAjzmSxQKjfU5MgwAGprZZKI7vUPdTOq8AXdqqBp5UxGFHNZgTZVPAW8CS3qtUG6uUIICsauXF7KnKwU20X-3W428WF7GkRiUl_l8hjRorstENWrkYSmzy3WLFAxFQNvHl0_-nNxsH3X39X7nYO8JucWLvdJgXG2S9el45p-CxTcdPCu2GSVfrnpf_wHo4WQH |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiplex+array+analysis+of+circulating+cytokines+and+chemokines+in+COVID-19+patients+during+the+first+wave+of+the+SARS-CoV-2+pandemic+in+Milan%2C+Italy&rft.jtitle=BMC+immunology&rft.au=Calvo-Alvarez%2C+Estefan%C3%ADa&rft.au=Sarah+D%E2%80%99Alessandro&rft.au=Zanotta%2C+Nunzia&rft.au=Basilico%2C+Nicoletta&rft.date=2024-07-26&rft.pub=BioMed+Central&rft.eissn=1471-2172&rft.volume=25&rft.spage=1&rft_id=info:doi/10.1186%2Fs12865-024-00641-z |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2172&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2172&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2172&client=summon |